{"organizations": [], "uuid": "1bad50ef9ec93b5dff2fc90f641b54e0ba98b674", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180206.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-biodelivery-sciences-announces-bel/brief-biodelivery-sciences-announces-belbuca-patent-litigation-settlement-agreement-with-teva-idUSFWN1PW0MP", "country": "US", "domain_rank": 408, "title": "BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.504, "site_type": "news", "published": "2018-02-06T20:08:00.000+02:00", "replies_count": 0, "uuid": "1bad50ef9ec93b5dff2fc90f641b54e0ba98b674"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-biodelivery-sciences-announces-bel/brief-biodelivery-sciences-announces-belbuca-patent-litigation-settlement-agreement-with-teva-idUSFWN1PW0MP", "ord_in_thread": 0, "title": "BRIEF-Biodelivery Sciences Announces Belbuca Patent Litigation Settlement Agreement With Teva", "locations": [], "entities": {"persons": [], "locations": [{"name": "biodelivery", "sentiment": "none"}, {"name": "usa", "sentiment": "none"}], "organizations": [{"name": "teva", "sentiment": "negative"}, {"name": "reuters) - biodelivery sciences international inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 6 (Reuters) - Biodelivery Sciences International Inc :\n* BIODELIVERY SCIENCES ANNOUNCES BELBUCA PATENT LITIGATION SETTLEMENT AGREEMENT WITH TEVA\n* BIODELIVERY SCIENCES - ENTERED INTO SETTLEMENT AGREEMENT WITH TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICALS INDUSTRIES, LTD.\n* BIODELIVERY SCIENCES - AGREEMENT RESOLVES BELBUCA (BUPRENORPHINE) BUCCAL FILM (CIII), PATENT LITIGATION AGAINST TEVA Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-06T20:08:00.000+02:00", "crawled": "2018-02-07T22:23:05.000+02:00", "highlightTitle": ""}